BPC-157 + TB-500
Public supplier report and marketplace listing from Sulan Bio.
Supplier testing information
Independently quantified peptide blend
Sulan Bio BPC-157 + TB-500 batch SUL0330-001 was independently analysed by Janoshik Laboratory under task #150942.
The analytical report recorded 11.98mg BPC-157 and 11.42mg TB-500 in the submitted sample, providing component-specific quantitative documentation for this marketplace listing.
Important: peptide purity was not included in this analysis. The report therefore documents the measured quantity of each component and should not be presented as a peptide-purity result.
What is the BPC-157 + TB-500 blend?
This research blend combines BPC-157 with TB-500 in a nominal 10mg + 10mg configuration. The two peptides are studied through different but potentially complementary areas of cellular and tissue biology.
BPC-157 is commonly investigated in experimental models involving cellular signalling, angiogenic pathways, fibroblast activity and tissue-remodelling processes.
TB-500 is associated with thymosin beta-4 (Tβ4) research and is commonly investigated in relation to actin regulation, cytoskeletal organisation, cell migration and tissue-remodelling pathways.
Common research areas
BPC-157 and TB-500-related pathways are commonly investigated in laboratory research examining:
- Cellular repair and regeneration signalling
- Cell migration and cellular motility
- Tissue-remodelling mechanisms
- Angiogenic and vascular signalling pathways
- Fibroblast and connective-tissue biology
- Actin regulation and cytoskeletal organisation
- Cell survival and stress-response pathways
- Inflammatory signalling in experimental models
Why study BPC-157 and TB-500 together?
The blend is of research interest because BPC-157 and TB-500 are associated with different areas of cellular signalling and tissue biology.
Experimental research may examine their respective effects on angiogenic signalling, fibroblast activity, actin dynamics, cell migration and tissue-remodelling pathways within the same laboratory model.
Available configuration
- BPC-157: nominal 10mg per vial
- TB-500: nominal 10mg per vial
- Total nominal peptide content: 20mg per vial
- Box configuration: 10 vials
- MOQ: 10 vials / 1 box
- Format: Lyophilized research peptide blend
- Supplier: Sulan Bio
Batch verification
- Supplier: Sulan Bio
- Batch: SUL0330-001
- Nominal blend: 10mg BPC-157 + 10mg TB-500
- Measured BPC-157: 11.98mg
- Measured TB-500: 11.42mg
- Measured combined content: 23.40mg
- Purity: Not included in this analysis
- Independent laboratory: Janoshik
- Task number: #150942
- Tested: 22 APR 2026
- COA status: Quantitative analysis available
This product is supplied strictly for laboratory research and analytical applications. It is not intended for human consumption, medical use, diagnostic use or clinical application.
BPC-157 + TB-500 laboratory testing questions
What is this BPC-157 + TB-500 report?
This report contains publicly accessible batch testing information for BPC-157 + TB-500, including task number #150942, reported purity results, and Janoshik-linked laboratory reference data.
Has this BPC-157 + TB-500 batch been laboratory tested?
Yes. This BPC-157 + TB-500 batch includes publicly accessible laboratory testing references, including reported purity result Blend Verified, task number #150942, and laboratory reference key WSLFFMGFLDXE.
Who supplied this BPC-157 + TB-500 batch?
Sulan Bio supplied this BPC-157 + TB-500 batch from China, with public batch testing references and tracked supplier fulfilment information.
What purity was reported for this BPC-157 + TB-500 batch?
The reported purity result for this BPC-157 + TB-500 batch was Blend Verified.
Where can I view additional BPC-157 + TB-500 reports?
Additional BPC-157 + TB-500 laboratory testing reports and supplier batch references can be viewed through the Buy China Peptides reports directory.